Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
Submitted by
admin
on September 11, 2008 - 7:44am
Source:
Yahoo
Headline:
Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
Do Not Allow Advertisers to Use My Personal information